{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.89A>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "C",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_000345.4:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation"
        },
        {
          "HGVS": "NM_000345.4:c.158T>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "T",
            "alt": "C",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0005338"
  },
  "Experiment Method": [
    {
      "Assay Method": "Fibrillization Assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Recombinant α-synuclein",
        "Description": "Recombinant human wild-type and mutant α-synuclein were expressed in Escherichia coli BL21(DE3) cells and purified."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Accelerates fibrillization",
          "Result Description": "A30P mutant fibrils accelerated the nucleation-dependent fibrillization of wild-type α-synuclein."
        },
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Promotes fibrillization",
          "Result Description": "E46K mutant fibrils promoted fibrillization of wild-type α-synuclein."
        },
        {
          "Variant": "NM_000345.4:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Promotes fibrillization",
          "Result Description": "A53T mutant fibrils promoted fibrillization of wild-type α-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Results are expressed as means ± S.E. of three independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein fibrils were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Monomeric α-synuclein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired Student's t test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fibrillization observed within 6 days.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fibrillization observed within 1.5 days.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Electron Microscopy",
      "Material used": {
        "Material Source": "Fibrils and seeds",
        "Material Name": "α-synuclein fibrils and seeds",
        "Description": "Fibrils and seeds were observed by electron microscopy."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased shedding of fragments",
          "Result Description": "A30P fibrils exhibited higher levels of fragment shedding compared to wild-type fibrils."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Results are expressed as means ± S.E. of three independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein fibrils were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Monomeric α-synuclein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired Student's t test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Long fibrils observed.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Short fibrils and fragments observed.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Dot Blot Assay",
      "Material used": {
        "Material Source": "Fibrils and seeds",
        "Material Name": "α-synuclein fibrils and seeds",
        "Description": "Equal amounts of serially diluted fibrils and seeds were spotted onto polyvinylidene difluoride membrane."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Different conformation",
          "Result Description": "A30P fibrils showed a distinct conformation from wild-type fibrils."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Results are expressed as means ± S.E. of three independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein fibrils were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Monomeric α-synuclein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired Student's t test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Strong immunoreactivity with syn1–10 and syn75–91.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Weak immunoreactivity with syn75–91 and strong immunoreactivity with syn1–10.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}